Allan Böhm

Seerlinq is taking non-invasive diagnostics, disease monitoring and treatment optimization to a new level by utilising state-of-the-art machine learning PPG analysis, and our medical expertise. We are reinventing the way of looking at the PPG curve by using artificial intelligence to analyse all measured parameters comprehensively. Furthermore, we are using our worldwide network of physicians and clinical researchers to collect medically labelled data. Our mission is to personalise treatment and diagnostics of cardiovascular diseases by analysing PPG signal with machine learning.